We have previously demonstrated that actively proliferating breast or prostate cancer cells stimulate osteoclast formation from RANKL‐primed precursors (Guo et al., 2008; Rafiei & Komarova, 2013; Tiedemann et al., 2009). Here, TNFSF11 is linked to prostate cancer.